Natraj Proteins Ltd Valuation Shifts: Price Attractiveness Improves Amid Mixed Returns

2 hours ago
share
Share Via
Natraj Proteins Ltd, a micro-cap player in the edible oil sector, has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating. Despite a recent downgrade in its overall Mojo Grade to 'Sell' from 'Strong Sell', the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest improved price attractiveness relative to peers and historical benchmarks. This article analyses the valuation changes, financial metrics, and market performance to provide a comprehensive view for investors.
Natraj Proteins Ltd Valuation Shifts: Price Attractiveness Improves Amid Mixed Returns

Valuation Metrics Show Positive Movement

As of 28 April 2026, Natraj Proteins Ltd trades at ₹36.85, down 5.10% from the previous close of ₹38.83. The stock’s 52-week range spans ₹28.00 to ₹47.90, indicating moderate volatility within the edible oil sector. The company’s P/E ratio currently stands at 10.70, a significant improvement from prior levels that contributed to its previous 'Very Attractive' valuation grade. This shift to an 'Attractive' valuation grade reflects a recalibration of market expectations and relative pricing.

The price-to-book value ratio is equally compelling at 0.47, signalling that the stock is trading below half its book value, a classic indicator of undervaluation in the micro-cap segment. Other valuation multiples such as EV/EBIT (9.91) and EV/EBITDA (9.02) further reinforce the stock’s relative affordability compared to sector averages.

Comparative Analysis with Industry Peers

When benchmarked against key competitors in the edible oil industry, Natraj Proteins’ valuation metrics present a mixed but generally favourable picture. For instance, AVT Natural Products, rated as 'Fair', trades at a P/E of 18.62 and EV/EBITDA of 12.84, considerably higher than Natraj’s multiples. Similarly, Gokul Refoils, also rated 'Attractive', has a P/E of 20.81 and EV/EBITDA of 13.59, underscoring Natraj’s relative valuation advantage.

However, some peers such as BCL Industries and KSE maintain 'Very Attractive' ratings with even lower P/E ratios of 8.61 and 5.38 respectively, and EV/EBITDA multiples of 6.46 and 3.04. This suggests that while Natraj Proteins has improved its valuation standing, there remain more attractively priced opportunities within the sector.

Financial Performance and Quality Metrics

Despite the improved valuation, Natraj Proteins’ return metrics remain subdued. The latest return on capital employed (ROCE) is a mere 1.03%, while return on equity (ROE) stands at 4.40%. These figures are modest compared to industry standards and may explain the cautious stance reflected in the Mojo Grade downgrade to 'Sell'. The company’s PEG ratio is exceptionally low at 0.06, indicating that earnings growth expectations are minimal or that the stock is undervalued relative to its growth potential.

Dividend yield data is not available, which may be a consideration for income-focused investors. The enterprise value to capital employed ratio of 0.69 and EV to sales of 0.32 further highlight the stock’s low valuation but also hint at limited operational efficiency or growth prospects.

This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!

  • - Precise target price set
  • - Weekly selection live
  • - Position check opportunity

Check Your Position →

Stock Performance Relative to Sensex

Examining Natraj Proteins’ stock returns against the Sensex index reveals a nuanced performance profile. Over the past week, the stock declined by 4.78%, underperforming the Sensex’s 1.55% drop. Over one month, the stock was nearly flat with a marginal loss of 0.14%, while the Sensex gained 5.06%. Year-to-date, however, Natraj Proteins has outperformed significantly with a 15.16% return compared to the Sensex’s negative 9.29%.

Longer-term returns paint a less favourable picture. The stock has declined 10.10% over the past year, while the Sensex fell by 2.41%. Over three years, Natraj Proteins has lost 24.83%, contrasting sharply with the Sensex’s 27.46% gain. Five- and ten-year returns are positive but modest at 11.84% and 11.33% respectively, compared to the Sensex’s robust 57.94% and 196.59% gains.

Valuation Grade and Mojo Score Implications

The company’s Mojo Score currently stands at 34.0, with a Mojo Grade of 'Sell', downgraded from 'Strong Sell' on 30 March 2026. This indicates a slight improvement in sentiment but still reflects caution due to the company’s financial and operational challenges. The micro-cap status adds an additional layer of risk and volatility, which investors should carefully consider.

While the valuation grade has improved from 'Very Attractive' to 'Attractive', this shift may reflect market adjustments to recent earnings or sector dynamics rather than a fundamental turnaround. Investors should weigh the valuation appeal against the company’s modest returns and peer comparisons before making allocation decisions.

Holding Natraj Proteins Ltd from Edible Oil? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!

  • - Peer comparison ready
  • - Superior options identified
  • - Cross market-cap analysis

Switch to Better Options →

Investor Takeaway: Balancing Valuation and Performance

Natraj Proteins Ltd presents an intriguing case for value-oriented investors seeking exposure to the edible oil sector. The stock’s improved valuation metrics, particularly the P/E of 10.70 and P/BV of 0.47, suggest it is attractively priced relative to many peers. However, the company’s low returns on capital and equity, combined with a modest PEG ratio, indicate limited growth prospects and operational challenges.

Investors should also consider the stock’s mixed performance against the broader market, with strong year-to-date gains offset by weaker longer-term returns. The downgrade in Mojo Grade to 'Sell' signals caution, reflecting underlying risks inherent in micro-cap stocks and the edible oil industry’s competitive landscape.

In summary, while Natraj Proteins offers valuation appeal, it remains essential to weigh this against fundamental performance and sector dynamics. A diversified approach, possibly incorporating more robust peers with very attractive valuations, may better serve investors seeking growth and stability in this space.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News